A detailed history of Janus Henderson Group PLC transactions in Immunic, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 7,073,844 shares of IMUX stock, worth $8.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,073,844
Previous 6,993,007 1.16%
Holding current value
$8.35 Million
Previous $9.23 Million 14.94%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.98 - $1.44 $79,220 - $116,405
80,837 Added 1.16%
7,073,844 $7.85 Million
Q1 2024

May 15, 2024

BUY
$1.14 - $1.53 $7.97 Million - $10.7 Million
6,993,007 New
6,993,007 $9.23 Million
Q3 2022

Nov 14, 2022

SELL
$3.0 - $5.49 $1.59 Million - $2.91 Million
-529,435 Reduced 62.74%
314,382 $990,000
Q2 2022

Aug 15, 2022

BUY
$3.13 - $12.25 $1.6 Million - $6.26 Million
510,828 Added 153.41%
843,817 $2.92 Million
Q1 2022

May 16, 2022

BUY
$9.54 - $14.26 $3.18 Million - $4.75 Million
332,989 New
332,989 $3.76 Million

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $36.1M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.